KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Insulet (PODD) EBITDA Margin (2016 - 2025)

Insulet's EBITDA Margin history spans 16 years, with the latest figure at 18.67% for Q4 2025.

  • For Q4 2025, EBITDA Margin rose 37.0% year-over-year to 18.67%; the TTM value through Dec 2025 reached 17.5%, up 259.0%, while the annual FY2025 figure was 17.5%, 258.0% up from the prior year.
  • EBITDA Margin reached 18.67% in Q4 2025 per PODD's latest filing, up from 16.66% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 20.89% in Q4 2023 to a low of 8.92% in Q2 2022.
  • Average EBITDA Margin over 5 years is 11.62%, with a median of 12.75% recorded in 2022.
  • Peak YoY movement for EBITDA Margin: skyrocketed 1817bps in 2021, then plummeted -1904bps in 2022.
  • A 5-year view of EBITDA Margin shows it stood at 15.2% in 2021, then plummeted by -58bps to 6.36% in 2022, then skyrocketed by 229bps to 20.89% in 2023, then decreased by -12bps to 18.29% in 2024, then grew by 2bps to 18.67% in 2025.
  • Per Business Quant, the three most recent readings for PODD's EBITDA Margin are 18.67% (Q4 2025), 16.66% (Q3 2025), and 18.66% (Q2 2025).